Enzalutamide in Patients With High-risk Prostate Cancer

NCT01927627 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Adenocarcinoma of the Prostate

Interventions

DRUG: enzalutamide

Sponsor

Case Comprehensive Cancer Center